30 Years of Improved Survival in Non-Transplant-Eligible Newly Diagnosed Multiple Myeloma

SIMPLE SUMMARY: Multiple myeloma mainly affects the elderly, who are usually not eligible to intensive treatments such as autologous stem cell transplant. Historically, the survival of these patients was short and there were few therapeutic options. Alkylating agents were the main options available...

Descripción completa

Detalles Bibliográficos
Autores principales: Chacon, Aurelia, Leleu, Xavier, Bobin, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093071/
https://www.ncbi.nlm.nih.gov/pubmed/37046589
http://dx.doi.org/10.3390/cancers15071929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093071/
https://www.ncbi.nlm.nih.gov/pubmed/37046589
http://dx.doi.org/10.3390/cancers15071929

Ejemplares similares